Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- exenatide
- turmeric
Interactions between your drugs
exenatide turmeric
Applies to: exenatide, turmeric
MONITOR: Coadministration of turmeric with antidiabetic drugs might potentiate the risk of hypoglycemia. Some small studies have shown that curcumin, the main component in turmeric, can reduce the blood levels of glucose and/or glycosylated hemoglobin (HbA1c) in diabetic patients. In a pharmacokinetic study involving eight type-2 diabetic patients, curcumin (475 mg daily) also increased glyburide (5 mg daily) blood levels by 12% at 2 hours after glyburide administration. The combination of glyburide and curcumin significantly decreased plasma glucose levels for up to 24 hours compared to glyburide alone. However, no patient experienced hypoglycemia.
MANAGEMENT: Caution is recommended if turmeric is coadministered with antidiabetic drugs. Blood glucose should be monitored, and patients should be educated on the potential signs and symptoms of hypoglycemia (e.g., headache, dizziness, drowsiness, nervousness, confusion, tremor, hunger, weakness, perspiration, palpitation, and tachycardia) and appropriate remedial actions to take if it occurs. Patients should also be advised to take precautions to avoid hypoglycemia while driving or operating hazardous machinery.
References (4)
- Neerati R, Devde R, Gangi AK (2014) "Evaluation of the effects of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus." Phytother Res, 28, p. 1796-1800
- Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M (2019) "The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial." Phytother Res, 33, p. 1374-83
- Chuengsamarn S, Rattanamongkolgul s, Luechapudiporn R, Phisalaphong C, Jirawatnotai S (2012) "Curcumin extract for prevention of type 2 diabetes." Diabetes Care, 35, p. 2121-7
- Hodaei H, Adibian M, Nikpayam O, Hedayati M, Sohrab G (2019) "The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial." Diabet Metab Syndr, 11, e-collection 2019
Drug and food interactions
exenatide food
Applies to: exenatide
ADJUST DOSING INTERVAL: Exenatide slows gastric emptying and may reduce the extent and rate of absorption of concomitantly administered oral medications. When acetaminophen 1000 mg was administered simultaneously with exenatide 10 mcg and also one hour, 2 hours, and 4 hours after exenatide injection, acetaminophen systemic exposure (AUC) was decreased by 21%, 23%, 24%, and 14%, respectively; peak plasma concentration (Cmax) was decreased by 37%, 56%, 54%, and 41%, respectively; and time to peak plasma concentration (Tmax) was increased from 0.6 hours in the control period to 0.9 hours, 4.2 hours, 3.3 hours, and 1.6 hours, respectively. These values were not significantly changed when acetaminophen was given one hour before exenatide injection.
MANAGEMENT: Concomitantly administered oral medications that are dependent on threshold concentrations for efficacy (e.g., antibiotics, contraceptives) or that require rapid gastrointestinal absorption (e.g., hypnotics, pain medications) should be administered at least 1 hour before exenatide. If such medications are to be administered with food, patients should be advised to take them with a meal or snack when exenatide is not administered.
References (1)
- (2005) "Product Information. Byetta (exenatide)." Amylin Pharmaceuticals Inc
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.